Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer.
about
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularEGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data.Minireview: the molecular and genomic basis for prostate cancer health disparitiesMolecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularRacial diversity of actionable mutations in non-small cell lung cancer.Non-Small-Cell Lung Cancer Clinicopathologic Features and Survival Outcomes in Asian Pacific Islanders Residing in the United States: A SEER AnalysisGenomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel SequencingEthnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma.Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis.Cancer genes in lung cancer: racial disparities: are there any?Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research.Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer.Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer.EGFR tyrosine kinase inhibitors: difference in efficacy and resistance.Prevalence of EGFR Mutations in Lung Cancer in Uruguayan Population.Lung Adenocarcinoma Survival in EGFR-Mutated African-Caribbean Patients: A Multicenter Study in the French West Indies.Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians.Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients.Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non-Small Cell Lung Cancer.Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations.Lung Cancer Health Disparities.Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity.
P2860
Q26828860-579604A8-DC08-4912-A556-69247869119DQ30915526-84CEB79E-9FDE-4C03-BA91-4FCC1350A433Q33633160-50E39C3D-1A88-41BF-AB3C-9C2E4FE48F43Q34159011-F9B06F1D-02F7-4613-8AD6-80BBCB9CC80AQ35007995-C9DCBD21-CB01-4327-AECB-7022E1B5A1C6Q35034103-4D48D255-20C9-4289-A03B-E4C9621B8991Q35671373-9DA75463-38D5-4E9B-B7A4-486A8D531794Q35943089-7B46EE3A-D044-43D1-8726-2D263CF11047Q35956330-CC75C536-07B1-44E9-A6ED-090EBE3ECB20Q36200850-002E9867-FB7D-451B-8BE4-41D223E752E6Q36481954-2F973C70-6C96-4E43-84C2-C239F500D85BQ37110396-9923C308-8078-4FB7-8625-CBA9B2FC0EC3Q37238134-8B80AFC6-86BC-46D7-8EAA-7A3AAB791312Q37288681-CDD69CDE-6669-49F2-8CD1-4D12B91B4A0FQ37581685-4E0EB735-7A22-4106-A1FF-222FF515A681Q37684483-B7C3779A-B8EA-41DD-8BF6-72FDA49676EDQ38106905-0DF2F4CA-3D01-46CE-B3C2-194E9278BED0Q38661269-B0B1981D-CAD6-4008-8E4C-68401043BD46Q38720804-D37A13AB-1A2D-4007-BCFB-A04085D2AF6FQ40368173-B296336D-7FCD-4782-B2EC-A17BBAA72493Q41027999-9EB7A9A0-B28C-455F-B441-ECCF7F52293CQ41612456-86D5FAE5-C9C7-4231-B5BD-65F0805D16B8Q44695743-5BCE2815-6E8B-4043-B37D-CCB241DF9812Q47110241-7D7A8BDE-34CD-476A-9CAB-18172C2D321BQ48478420-BDE62AF9-150B-4303-8C6E-F2D4336C49C7Q53177073-7D20C94C-D8C0-4371-BBD5-B291C848013EQ55242701-7A9398EF-BA9E-48C1-9317-F8CFB9986483
P2860
Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Frequency and type of epiderma ...... th non-small cell lung cancer.
@ast
Frequency and type of epiderma ...... th non-small cell lung cancer.
@en
Frequency and type of epiderma ...... th non-small cell lung cancer.
@nl
type
label
Frequency and type of epiderma ...... th non-small cell lung cancer.
@ast
Frequency and type of epiderma ...... th non-small cell lung cancer.
@en
Frequency and type of epiderma ...... th non-small cell lung cancer.
@nl
prefLabel
Frequency and type of epiderma ...... th non-small cell lung cancer.
@ast
Frequency and type of epiderma ...... th non-small cell lung cancer.
@en
Frequency and type of epiderma ...... th non-small cell lung cancer.
@nl
P2093
P2860
P1476
Frequency and type of epiderma ...... th non-small cell lung cancer.
@en
P2093
Ann G Schwartz
Ayman O Soubani
David J Edwards
Fulvio Lonardo
Gerold Bepler
Govindaraja Atikukke
Michele L Cote
Ramsi Haddad
Shirish Gadgeel
Stephen P Ethier
P2860
P304
P356
10.1097/JTO.0B013E31820A0EC0
P577
2011-03-01T00:00:00Z